COVID-19-associated stroke: experience of Regional clinical hospital Krasnoyarsk city

Abstract

Mechanisms of the impact of the new coronavirus infection on nervous system that leads to various neurological complications, including strokes, and disease patterns and prognosis for stroke patients with COVID-19 are actively discussed in the literature. The aim of the research was a comparison of clinical outcomes in stroke patients with SARS-CoV-2 infection and without. Random sampling of patients with stroke and laboratory-confirmed coronavirus infection SARS-CoV-2 (50 patients) was analyzed retrospectively. The control group consisted of 49 patients with stroke who did not have COVID-19. Patients in both groups were comparable by age, sex, rate of variation and type of stroke, localization of stroke and rating on the Rankin scale before the disease. The results showed that diabetes mellitus significantly more often (more than twice) occurred in stroke patients with COVID-19 (16%) in comparison with the control (7%). Atherosclerosis of brachiocephalic arteries prevailed in acute stroke patients without COVID-19 (88%). The mortality rate in acute stroke patients with COVID-19 was higher (22%) than among those without this infection (6%). At the same time, patients without a combination with COVID-19 had more severe disability on the Rankin scale – three points (moderate disability) – while patients with COVID-19 were discharged with two points on the Rankin scale (slight disability). Probably, this is since SARS-CoV-2 infection more often led to the lethal oucome in patients with more severe stroke and the survived patients were less disabled. Probably in increased samples these differences will be reversed. Thus, this research confirmed data that the association of stroke and COVID-19 significantly worsens clinical outcomes of stroke (2 tables, bibliography: 10 refs)

Keywords

angioneurology / COVID-19 / mortality / neurological complications / Rankin scale / SARS-COV-2 / stroke

References

[1] Yanishevskii SN, Tsygan NV, Golokhvastov SYu, et al. Modern strategies of protection of hypoxic-ishemic brain damage. Neuroscience and Behavioral Physiology. 2017;117(12(2):78–86. (In Russ.) DOI: 10.17116/jnevro201711712278-86

[2] Янишевский С.Н., Цыган Н.В., Голохвастов С.Ю., и др. Современные стратегии защиты при гипоксически-ишемическом повреждении головного мозга // Журнал неврологии и психиатрии им. C.C. Корсакова. 2017. Т. 117, № 12 (2). С. 78–86. DOI: 10.17116/jnevro201711712278-86

[3] Andreev VV, Podunov AY, Lapin DS, et al. Clinical and pathogenetic features of cerebral stroke in patients with new corоnavirus infection (COVID-19). Regional hemodynamics and microcirculation. 2020;19(3):46–56. (In Russ.) DOI: 10.24884/1682-6655-2020-19-3-46-56

[4] Андреев В.В., Подунов А.Ю., Лапин Д.С., и др. Клинико-патогенетические особенности церебрального инсульта у больных с новой коронавирусной инфекцией (COVID-19) // Регионарное кровообращение и микроциркуляция. 2020. № 19 (3). С. 46–56. DOI: 10.24884/1682-6655-2020-19-3-46-56

[5] Vogrig A, Gigli GL, Bna C, Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neuroscience Letters. 2021;743:135564. DOI: 10.1016 / j.neulet.2020.135564

[6] Vogrig A., Gigli G.L., Bna C., Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics // Neuroscience Letters. 2021. No. 743. P. 135564. DOI: 10.1016 / j.neulet.2020.135564

[7] Cai Q, Huang D, Ou P, et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75(7):1742–1752. DOI: 10.1111/all.14309

[8] Cai Q., Huang D., Ou P., et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. // Allergy. 2020. No. 75 (7). P. 1742–1752. DOI: 10.1111/all.14309

[9] Yaghi, S, Ishida K, Torres J, et al. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;7(51):2002–2011. DOI: 10.1161/STROKEAHA.120.030335

[10] Yaghi S., Ishida K., Torres J., et al. SARS-CoV-2 and Stroke in a New York Healthcare System // Stroke. 2020. No. 7 (51). P. 2002–2011. DOI: 10.1161/STROKEAHA.120.030335

[11] Pizova NV, Pizov NA, Skachkova OA, et al. Acute cerebral circulatory disorders and coronavirus disease. Meditsinskiy sovet. 2020;(8):18–25. (In Russ.) DOI: 10.21518/2079-701X-2020-8-20-27

[12] Пизова Н.В., Пизов Н.А., Скачкова О.А., и др. Острые нарушения мозгового кровообращения и коронавирусная болезнь // Медицинский совет. 2020. № 8. С. 18–25. DOI: 10.21518/2079-701X-2020-8-20-27

[13] Bubnova MG, Aronov DM. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation. Pulmonologiya. 2020;30(5): 688–699. (In Russ.) DOI: 10.18093/0869-0189-2020-30-5-688-699

[14] Бубнова М.Г., Аронов Д.М. COVID-19 и сердечно-сосудистые заболевания: от эпидемиологии до реабилитации // Пульмонология. 2020. № 30 (5). С. 688–699. DOI: 10.18093/0869-0189-2020-30-5-688-699

[15] Gusev EI, Martynov MYu, Boiko AN, et al. Novel coronavirus infection (COVID-19) and nervous system involvement: pathoge nesis, clinical manifestations, organization of neurological care. Neuroscience and Behavioral Physiology. 2020;120(6):7–16. (In Russ.) DOI: 10.17116/jnevro20201200617

[16] Гусев Е.И., Мартынов М.Ю., Бойко А.Н., и др. Новая коронавирусная инфекция (COVID-19) и поражение нервной системы: механизмы неврологических расстройств, клинические проявления, организация неврологической помощи // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020. Т. 120, № 6. С. 7–16. DOI: 10.17116/jnevro20201200617

[17] Zaytsev AA, Chernov SA, Stets VV, et al. Algorithms of the management of patients with a new coronavirus infection COVID-19 in the hospital: guidelines. Consilium Medicum. 2020;22(11):91–97. (In Russ.) DOI: 10.26442/20751753.2020.11.200520

[18] Зайцев А.А., Чернов С.А., Стец В.В., и др. Алгоритмы ведения пациентов с новой коронавирусной инфекцией COVID-19 в стационаре. методические рекомендации // Consilium Medicum. 2020. Т. 22, № 11. С. 91–97. DOI: 10.26442/20751753.2020.11.200520

[19] Qureshi AI, Baskett WI, Huang W, et al. Acute Ischemic Stroke and COVID-19. An Analysis of 27 676 Patients. Stroke. 2021;52(3): 905–912. DOI: 10.1161/STROKEAHA.120.031786

[20] Qureshi A.I., Baskett W.I., Huang W., et al. Acute Ischemic Stroke and COVID-19. An Analysis of 27 676 Patients // Stroke. 2021. Vol. 52, No. 3. P. 905–912. DOI: 10.1161/STROKEAHA.120.031786

RIGHTS & PERMISSIONS

Prokopenko S.V., Isayeva N.V., Bezdeneznykh A.F., Alekseevich G.Y., Lukianova E.V., Medvedeva M.K., Veber I.S., Severina M.I., Kazadayeva I.A.